|
1
|
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
|
J Surg Oncol
|
2006
|
1.75
|
|
2
|
Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
|
J Clin Oncol
|
2005
|
0.98
|
|
3
|
The role of radiotherapy in management of pancreatic cancer.
|
J Gastrointest Oncol
|
2011
|
0.97
|
|
4
|
Isolated post-traumatic right-sided diaphragmatic hernia.
|
Indian J Pediatr
|
2010
|
0.90
|
|
5
|
Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancer.
|
Clin Lung Cancer
|
2002
|
0.88
|
|
6
|
Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
|
Laryngoscope
|
2004
|
0.85
|
|
7
|
Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10).
|
Urol Oncol
|
2008
|
0.81
|
|
8
|
Mucosa-associated lymphoid tissue lymphoma and concurrent adenocarcinoma of the prostate.
|
Rare Tumors
|
2010
|
0.78
|
|
9
|
A new paradigm for the treatment of high-risk prostate cancer: radiosensitization with docetaxel.
|
Rev Urol
|
2003
|
0.78
|
|
10
|
Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT).
|
Arch Otolaryngol Head Neck Surg
|
2004
|
0.76
|
|
11
|
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
|
J Appl Clin Med Phys
|
2016
|
0.75
|